Skip to search boxSkip to navigationSkip to main content

Macrophage polarization: Different gene signatures in M1(Lps+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Macrophages are found in tissues, body cavities, and mucosal surfaces. Most tissue macrophages are seeded in the early embryo before definitive hematopoiesis is established. Others are derived from blood monocytes. The macrophage lineage diversification and plasticity are key aspects of their functionality. Macrophages can also be generated from monocytes in vitro and undergo classical (LPS+IFN-γ) or alternative (IL-4) activation. In vivo, macrophages with different polarization and different activation markers coexist in tissues. Certain mouse strains preferentially promote T-helper-1 (Th1) responses and others Th2 responses. Their macrophages preferentially induce iNOS or arginase and have been called M1 and M2, respectively. In many publications, M1 and classically activated and M2 and alternatively activated are used interchangeably. We tested whether this is justified by comparing the gene lists positively [M1(=LPS+)] or negatively [M2(=LPS-)] correlated with the ratio of IL-12 and arginase 1 in transcriptomes of LPS-treated peritoneal macrophages with in vitro classically (LPS, IFN-γ) vs. alternatively activated (IL-4) bone marrow derived macrophages, both from published datasets. Although there is some overlap between in vivo M1(=LPS+) and in vitro classically activated (LPS+IFN-γ) and in vivo M2(=LPS-) and in vitro alternatively activated macrophages, many more genes are regulated in opposite or unrelated ways. Thus, M1(=LPS+) macrophages are not equivalent to classically activated, and M2(=LPS-) macrophages are not equivalent to alternatively activated macrophages. This fundamental discrepancy explains why most surface markers identified on in vitro generated macrophages do not translate to the in vivo situation. Valid in vivo M1/M2 surface markers remain to be discovered.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Original language

English (US)

Article number

1084

Journal (Volume, Issue Number)

Frontiers in immunology (Volume 10, Issue MAY)

Publication milestones

  • Published - 2019

Publication status

Published - 2019

Publication IDs

  • Scopus: 85067541206
  • PubMed: 31178859

Publication metrics

Metrics

Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
1846
Mentions
8
Social media
1
Captures
1948

Funding Details

This study was funded by the National Institutes of Health R01 HL115232 (to KL), and American Heart Association post-doctoral fellowship AHA18POST34060251 (to MO).
FundersFunding numbers
NIH
-
NHLBI
R01HL115232
AHA
AHA18POST34060251